|
PCRX
|
Pacira Pharmaceuticals, Inc.
|
0.70%
|
US
|
NASDAQ
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
0.69%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
0.68%
|
US
|
NASDAQ
|
|
RVNC
|
Revance Therapeutics, Inc.
|
0.67%
|
US
|
NASDAQ
|
|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
0.66%
|
US
|
NASDAQ
|
|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
0.61%
|
US
|
NASDAQ
|
|
AMPH
|
Amphastar Pharmaceuticals, Inc.
|
0.45%
|
US
|
NASDAQ
|
|
SAVA
|
Cassava Sciences, Inc.
|
0.44%
|
US
|
NASDAQ
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
0.44%
|
US
|
NASDAQ
|
|
DICE
|
DICE Therapeutics, Inc.
|
0.43%
|
US
|
NASDAQ
|
|
RETA
|
Reata Pharmaceuticals, Inc. - Class A
|
0.41%
|
US
|
NASDAQ
|
|
COLL
|
Collegium Pharmaceutical, Inc.
|
0.40%
|
US
|
NASDAQ
|
|
VTYX
|
Ventyx Biosciences, Inc.
|
0.37%
|
US
|
NASDAQ
|
|
INVA
|
Innoviva, Inc.
|
0.35%
|
US
|
NASDAQ
|
|
ACRS
|
Aclaris Therapeutics, Inc.
|
0.35%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
0.27%
|
US
|
NASDAQ
|
|
CARA
|
Cara Therapeutics, Inc.
|
0.20%
|
US
|
NASDAQ
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
0.17%
|
US
|
NASDAQ
|
|
AVIR
|
Atea Pharmaceuticals, Inc.
|
0.15%
|
US
|
NASDAQ
|